The first stop for professional medicines advice

Medicines planning

61 results

Applied filters

Planning for a PGD

30 July 2024You’ve decided a PGD is the most appropriate option but there are things to consider before you start writing.

How to develop a Patient Group Direction

9 June 2022A guide to help organisations and individuals navigate all stages of the PGD development process.

Monitoring and reviewing a PGD in practice

30 July 2024Monitoring and evaluating practice under a PGD and timely review of a PGD are important steps in the development process.

Preparing to use ranibizumab biosimilar

29 June 2022Ranibizumab biosimilar needs planning. Ensure you are familiar with the area and then develop an implementation plan working with the multidisciplinary team

The licence and supporting evidence for eculizumab biosimilars

6 March 2024Two licensed eculizumab biosimilars are available: Bekemv and Epysqli. Learn about the licensed indications, supporting evidence and key differences.

NHS prescription charges for PGDs or HMR 2012 exemptions

16 November 2021This article summarises the position regarding the levying of prescription charges for medicines supplied under a PGD or an exemption to the HMR 2012.

New Medicines News

5 January 2023

Good governance when implementing natalizumab biosimilar

6 February 2024Governance should consider processes for approval, procurement and supply, prescribing and administration, monitoring and pharmacovigilance.

Understanding Patient Group Directions and Integrated Care Boards

3 May 2023We outline the responsibilities of ICBs in England as commissioners of NHS services using PGDs, and link to resources that provide further support and advice.

National Homecare Medicines Committee (NHMC) Homecare Service Proposal (HSP) Form

9 April 2019The Homecare Service Proposal (HSP) Form is to be completed by pharmaceutical manufacturers where there are new homecare medicines services or where there are changes…
admin